Latest immunotherapy News | Page 10

Two Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
Ludwig Cancer Research scientists to present at AACR Annual Meeting
Surprise finding shows neutrophils can fight tumors
International partnership launches Monash University-Helmholtz lab to solve global oncology, cardiology and infectious disease challenges
Top talent to boost cancer research
Immutep announces initiation of new breast cancer trial
Exposing tumours to bacteria converts immune cells to cancer killers
Exposing cancers to bacteria reminds first responder immune
Running buddies step up for breast cancer survivor Sarah
When it comes to food allergies, trust your gut
Baylor receives more than $5.8 million in CPRIT funding
Genetic study: Unexpectedly high variation in T-cell receptor genes between persons
Major genetic study reveals unexpectedly high variation in T-cell receptor genes between persons
‘Natural killer’ immune cells can modify tissue inflammation: study
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
New immunotherapy holds promise for ovarian cancer
New tech opens doors for cancer detection
The Ludwig Institute for Cancer Research appoints two new members to its Board of Directors
Scientists detail major mechanism lung cancers use to evade immune attack
Is a vaccine for melanoma on the cards?
Cellular messengers improve cancer therapy
Potential therapy for aggressive type of colon cancer shows promise
Govt Funds Lung Cancer Meds Keytruda & Tecentriq
Seven QIMR Berghofer research projects awarded prestigious national grants
$8 million awarded to UniSA researchers to tackle cancer, medicine harm, vascular disease and miscarriages
Preoperative immunotherapy for mesothelioma shows favorable outcomes
Datopotamab deruxtecan showed promising responses as monotherapy and in combination with Imfinzi
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
Why autistic children are more likely to have gut problems
Immutep announces new collaboration for cancer treatment combination
5 Things to Know about Skin cancer
Ludwig Cancer Research study finds common, targetable mechanism tumors use to suppress immune responses
QIMR and WEHI take home prizes for best early-stage project
Hay fever can sometimes be more serious than we think
DNA barcoding reveals cancer cells’ ability to evade imm
Vaccination with senescent cells reduced tumor formation in mice
Landmark study finds home screening test can help prevent type 1 diabetes
Lung cancer champion urges people to take symptom seriously
New melanoma breakthrough by Australian company could potentially save thousands of lives
Ludwig Chicago nanotechnology indicues therapeutic immune responses against multiple types of tumors
Camizestrant significantly improved progression-free survival in advanced ER-positive breast cancer
Capivasertib Phase III trial met primary endpoints
Do hypoallergenic cats even exist?
Gene signature points to prognosis in kidney cancer
2 researchers improving treatment for people affected by advanced melanoma
$5.4 million boost for brain cancer research
Going with your gut
Second fast-track designation for Australian immunotherapy company